CHU de Charleroi Hopital Civil Marie Curie
- Address
- Chaussée de Bruxelles 140, 6042 Charleroi, Belgium
CHU de Charleroi Hopital Civil Marie Curie - Cardiovascular & Emergency Medicine Research
CHU de Charleroi Hopital Civil Marie Curie is a comprehensive academic medical center conducting advanced clinical research in critical cardiovascular interventions and emergency medicine. The center demonstrates particular expertise in managing complex patients requiring sophisticated antithrombotic strategies and post-resuscitation care.
- Antithrombotic therapy optimization in atrial fibrillation patients undergoing percutaneous coronary intervention
- Post-cardiac arrest neurological care and seizure management
- Novel anticoagulation strategies following coronary stent implantation
The research portfolio emphasizes innovative approaches to balancing bleeding and thrombotic risks in high-risk cardiovascular patients, including studies of P2Y12 inhibitor monotherapy and direct oral anticoagulant (DOAC) regimens following PCI. The center also focuses on neurological complications following cardiopulmonary resuscitation, investigating targeted anti-seizure treatment protocols for electroencephalographic status epilepticus in comatose cardiac arrest survivors, combining clinical efficacy assessment with health economic evaluation.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 of 5 therapeutic areas and 15 of 40 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 9 by active trials.
- 1Insel Gruppe AG2active
lock +8 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Insel Gruppe AG3trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 307 other sites in Belgium
Therapeutic Area Benchmark — Belgium
Select a therapeutic area to compare against other sites in Belgium.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Belgium
Market Share
Country: Belgium
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in CHU de Charleroi Hopital Civil Marie Curie
lock Showing 1 of 10 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Acetylsalicylic Acid and Clopidogrel Monotherapy for Secondary Prevention in Intracerebral Hemorrhage Survivors: A Randomized Controlled Trial | University Of Edinburgh | Phase III | Recruiting | Oct 2025 | — |
IMP list
lock Showing 1 of 40 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Acetylsalicylic Acid | 3 | Unknown | 2024-12-16 | 2026-01-26 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.